AR043650A1 - Formulacion dispersable de un agente antiinflamatorio para ser aplicada en inflamaciones mamarias en animales productores de leche y en inflamaciones oticas - Google Patents
Formulacion dispersable de un agente antiinflamatorio para ser aplicada en inflamaciones mamarias en animales productores de leche y en inflamaciones oticasInfo
- Publication number
- AR043650A1 AR043650A1 ARP040100903A ARP040100903A AR043650A1 AR 043650 A1 AR043650 A1 AR 043650A1 AR P040100903 A ARP040100903 A AR P040100903A AR P040100903 A ARP040100903 A AR P040100903A AR 043650 A1 AR043650 A1 AR 043650A1
- Authority
- AR
- Argentina
- Prior art keywords
- inflammatory agent
- inflammations
- otic
- producing animals
- milk producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Se proporciona un procedimiento para el tratamiento de una afección inflamatoria en un órgano que contiene fluido que tiene un orificio natural exterior, tal como la ubre de un animal productor de leche o oído. El procedimiento comprende la administración, al órgano a través del orificio exterior, de una composición farmacéutica que comprende un agente antiinflamatorio y un vehículo que comprende una aceite anfipático que es dispersable en agua e insoluble en etanol cera microcristalina y un vehículo no acuoso farmacéuticamente aceptable. También se proporciona dicha composición que comprende el agente antiinflamatorio por ejemplo antiinflamatorios no esteroides, esteroides e inhibidores de la ciclooxigenasa-2. La composición es fácilmente dispersable en el fluido de los órganos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45632503P | 2003-03-20 | 2003-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043650A1 true AR043650A1 (es) | 2005-08-03 |
Family
ID=33030094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040100903A AR043650A1 (es) | 2003-03-20 | 2004-03-18 | Formulacion dispersable de un agente antiinflamatorio para ser aplicada en inflamaciones mamarias en animales productores de leche y en inflamaciones oticas |
Country Status (26)
Country | Link |
---|---|
US (1) | US20040235803A1 (es) |
EP (1) | EP1608407B1 (es) |
JP (1) | JP2006520779A (es) |
KR (1) | KR100717433B1 (es) |
CN (1) | CN1761487A (es) |
AR (1) | AR043650A1 (es) |
AT (1) | ATE337793T1 (es) |
AU (1) | AU2004222523A1 (es) |
BR (1) | BRPI0408556A (es) |
CA (1) | CA2519125A1 (es) |
CL (1) | CL2004000573A1 (es) |
CO (1) | CO5611169A2 (es) |
CY (1) | CY1105652T1 (es) |
DE (1) | DE602004002201T2 (es) |
DK (1) | DK1608407T3 (es) |
ES (1) | ES2270361T3 (es) |
MX (1) | MXPA05009978A (es) |
NO (1) | NO20054260L (es) |
PL (1) | PL1608407T3 (es) |
PT (1) | PT1608407E (es) |
RU (1) | RU2325189C2 (es) |
SI (1) | SI1608407T1 (es) |
TW (1) | TWI262084B (es) |
UY (1) | UY28235A1 (es) |
WO (1) | WO2004082588A2 (es) |
ZA (1) | ZA200506920B (es) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7854943B2 (en) * | 2004-06-24 | 2010-12-21 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
US7858115B2 (en) * | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
US7618651B2 (en) * | 2004-06-24 | 2009-11-17 | Idexx Laboratories | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
EP2303026B1 (en) | 2008-06-17 | 2020-09-09 | Brigham Young University | Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods |
GB2477590A (en) * | 2010-02-05 | 2011-08-10 | Biocopea Ltd | A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier |
TR201002473A2 (tr) * | 2010-03-31 | 2011-09-21 | Mustafa Nevzat �La� Sanay�� A.�. | Herpes zoster hastalığının bır opiat reseptör antagonist kullanılarak tedavi yöntemi. |
US8685381B2 (en) | 2010-10-23 | 2014-04-01 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
US8968755B2 (en) | 2010-10-23 | 2015-03-03 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US8895536B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating chronic inflammation and inflammatory diseases |
US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
GB201020032D0 (en) * | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
CN104039369B (zh) | 2011-07-20 | 2017-06-16 | 布莱阿姆青年大学 | 疏水性塞拉集宁化合物和包含该化合物的装置 |
US9694019B2 (en) | 2011-09-13 | 2017-07-04 | Brigham Young University | Compositions and methods for treating bone diseases and broken bones |
US9603859B2 (en) | 2011-09-13 | 2017-03-28 | Brigham Young University | Methods and products for increasing the rate of healing of tissue wounds |
EP2793832B1 (en) | 2011-12-21 | 2018-05-23 | Brigham Young University | Oral care compositions |
US9533063B1 (en) | 2012-03-01 | 2017-01-03 | Brigham Young University | Aerosols incorporating ceragenin compounds and methods of use thereof |
US10039285B2 (en) | 2012-05-02 | 2018-08-07 | Brigham Young University | Ceragenin particulate materials and methods for making same |
RU2486905C1 (ru) * | 2012-05-28 | 2013-07-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ФГБОУ ВПО "КубГТУ") | Средство для лечения мастита у животных |
CA2888259C (en) * | 2012-10-17 | 2019-05-28 | Brigham Young University | Treatment and prevention of mastitis |
EP2941253B1 (en) | 2013-01-07 | 2021-08-11 | Brigham Young University | Cationic steroid antimicrobial agents for use in treating cancer |
NZ710757A (en) * | 2013-02-08 | 2020-04-24 | Luoda Pharma Ltd | Methods of treating microbial infections, including mastitis |
AU2014234992B2 (en) | 2013-03-15 | 2018-01-18 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US11524015B2 (en) | 2013-03-15 | 2022-12-13 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US10568893B2 (en) | 2013-03-15 | 2020-02-25 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US9387215B2 (en) | 2013-04-22 | 2016-07-12 | Brigham Young University | Animal feed including cationic cholesterol additive and related methods |
JP6539274B2 (ja) | 2013-08-12 | 2019-07-03 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | 押出成形された即放性乱用抑止性丸剤 |
US11690855B2 (en) | 2013-10-17 | 2023-07-04 | Brigham Young University | Methods for treating lung infections and inflammation |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
CA3209762A1 (en) | 2013-12-20 | 2015-09-17 | President And Fellows Of Harvard College | Organomimetic devices and methods of use and manufacturing thereof |
US20150203527A1 (en) | 2014-01-23 | 2015-07-23 | Brigham Young University | Cationic steroidal antimicrobials |
CA2844321C (en) | 2014-02-27 | 2021-03-16 | Brigham Young University | Cationic steroidal antimicrobial compounds |
US9867836B2 (en) | 2014-03-13 | 2018-01-16 | Brigham Young University | Lavage and/or infusion using CSA compounds for increasing fertility in a mammal |
US10220045B2 (en) | 2014-03-13 | 2019-03-05 | Brigham Young University | Compositions and methods for forming stabilized compositions with reduced CSA agglomeration |
US9931350B2 (en) | 2014-03-14 | 2018-04-03 | Brigham Young University | Anti-infective and osteogenic compositions and methods of use |
US9686966B2 (en) | 2014-04-30 | 2017-06-27 | Brigham Young University | Methods and apparatus for cleaning or disinfecting a water delivery system |
US10238665B2 (en) | 2014-06-26 | 2019-03-26 | Brigham Young University | Methods for treating fungal infections |
US10441595B2 (en) | 2014-06-26 | 2019-10-15 | Brigham Young University | Methods for treating fungal infections |
JP6371463B2 (ja) | 2014-07-17 | 2018-08-08 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | 即時放出性乱用抑止性液体充填剤形 |
RU2557691C1 (ru) * | 2014-07-25 | 2015-07-27 | Государственное бюджетное учреждение здравоохранения города Москвы "Московский научно-практический Центр оториноларингологии им Л.И. Свержевского" Департамента здравоохранения города Москвы | Способ определения длительности лечения активных форм отосклероза |
US10227376B2 (en) | 2014-08-22 | 2019-03-12 | Brigham Young University | Radiolabeled cationic steroid antimicrobials and diagnostic methods |
US10155788B2 (en) | 2014-10-07 | 2018-12-18 | Brigham Young University | Cationic steroidal antimicrobial prodrug compositions and uses thereof |
AU2015336065A1 (en) | 2014-10-20 | 2017-05-04 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
CN104688554A (zh) * | 2015-01-30 | 2015-06-10 | 柳州两面针股份有限公司 | 水杨苷在制备口腔护理保健品中的应用 |
US9527883B2 (en) | 2015-04-22 | 2016-12-27 | Brigham Young University | Methods for the synthesis of ceragenins |
WO2016172543A1 (en) | 2015-04-22 | 2016-10-27 | Savage Paul B | Methods for the synthesis of ceragenins |
US9434759B1 (en) | 2015-05-18 | 2016-09-06 | Brigham Young University | Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds |
KR101625020B1 (ko) | 2016-02-11 | 2016-06-01 | 최예도 | 식기세척기 |
US10226550B2 (en) | 2016-03-11 | 2019-03-12 | Brigham Young University | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
US10959433B2 (en) | 2017-03-21 | 2021-03-30 | Brigham Young University | Use of cationic steroidal antimicrobials for sporicidal activity |
KR102099363B1 (ko) * | 2017-09-08 | 2020-04-10 | 동국제약 주식회사 | 아보카도 오일 분획을 유효성분으로 포함하는 난청의 예방 또는 치료용 약학적 조성물 |
EP3603645A1 (en) | 2018-07-30 | 2020-02-05 | Virbac | Novel use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3636194A (en) * | 1969-10-23 | 1972-01-18 | Douglas G Parizeau | Composition and method for treating mastitis with therapeutic agents |
DE2063896A1 (de) * | 1970-12-28 | 1972-07-20 | Dynamit Nobel Ag, 5210 Troisdorf | Salbengrundlagen auf der Basis von Triglyceriden gesättigter mittelkettiger Fettsäuren und Verfahren zu deren Herstellung |
US4299501A (en) * | 1979-08-10 | 1981-11-10 | Ortho Pharmaceutical Corporation | Continuous process for the preparation of semisolid dispersions |
ES2079994B1 (es) * | 1992-10-07 | 1996-08-01 | Cusi Lab | Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica. |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
AU708964B2 (en) * | 1995-05-25 | 1999-08-19 | G.D. Searle & Co. | Method of preparing 3-haloalkyl-1h-pyrazoles |
DE69620136T2 (de) * | 1995-06-06 | 2002-08-01 | Bayer Ag | Antibakterielle präparate für die ohren ohne irritierende, sensibilisierende und ototoxische wirkungen |
US5756529A (en) * | 1995-09-29 | 1998-05-26 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies |
AP9700912A0 (en) * | 1996-01-11 | 1997-01-31 | Smithkline Beecham Corp | Novel cycloalkyl substituted imidazoles |
CN1098256C (zh) * | 1996-04-12 | 2003-01-08 | G·D·瑟尔公司 | 作为cox-2抑制剂前药的取代的苯磺酰胺衍生物 |
US5736151A (en) * | 1996-12-09 | 1998-04-07 | Pharmacia & Upjohn Company | Antibiotic oil suspensions |
US6307047B1 (en) * | 1997-08-22 | 2001-10-23 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
US6395746B1 (en) * | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
US6509327B1 (en) * | 1998-09-30 | 2003-01-21 | Alcon Manufacturing, Ltd. | Compositions and methods for treating otic, ophthalmic and nasal infections |
US6440964B1 (en) * | 1998-09-30 | 2002-08-27 | Alcon Manufacturing, Ltd. | Compositions and methods for treating ophthalmic and otic infections |
AR020660A1 (es) * | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Composiciones antibioticas para el tratamiento de ojos, oidos y nariz |
US7064132B2 (en) * | 1999-11-28 | 2006-06-20 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis external |
US6676930B2 (en) * | 1999-11-28 | 2004-01-13 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
RU2002119574A (ru) * | 1999-12-23 | 2004-01-10 | Нитромед, Инк. (Us) | Нитрозированные и нитрозилированные ингибиторы циклооксигеназы-2, композиции на их основе и способы их применения |
US20010049366A1 (en) * | 2000-02-09 | 2001-12-06 | Alcon Universal Ltd. | Topical solution formulations containing an antibiotic and a corticosteroid |
AU2001251011A1 (en) * | 2000-03-27 | 2001-10-08 | The General Hospital Corporation | Treatments for immune-mediated ear disorders |
EP1282435A2 (en) * | 2000-05-12 | 2003-02-12 | Immunex Corporation | Interleukin-1 inhibitors in the treatment of diseases |
US20020188016A9 (en) * | 2000-06-08 | 2002-12-12 | Peterson Johnny W. | Heterocycle derivatives and methods of use |
DE60131537T2 (de) * | 2000-06-22 | 2008-10-23 | Nitromed, Inc., Lexington | Nitrosierte und nitrosylierte taxane, zubereitungen und methoden der verwendung |
-
2004
- 2004-03-10 ES ES04719030T patent/ES2270361T3/es not_active Expired - Lifetime
- 2004-03-10 CN CNA2004800075939A patent/CN1761487A/zh active Pending
- 2004-03-10 MX MXPA05009978A patent/MXPA05009978A/es not_active Application Discontinuation
- 2004-03-10 KR KR1020057017576A patent/KR100717433B1/ko not_active IP Right Cessation
- 2004-03-10 CA CA002519125A patent/CA2519125A1/en not_active Abandoned
- 2004-03-10 AU AU2004222523A patent/AU2004222523A1/en not_active Abandoned
- 2004-03-10 PT PT04719030T patent/PT1608407E/pt unknown
- 2004-03-10 SI SI200430079T patent/SI1608407T1/sl unknown
- 2004-03-10 WO PCT/IB2004/000826 patent/WO2004082588A2/en active IP Right Grant
- 2004-03-10 DK DK04719030T patent/DK1608407T3/da active
- 2004-03-10 AT AT04719030T patent/ATE337793T1/de not_active IP Right Cessation
- 2004-03-10 DE DE602004002201T patent/DE602004002201T2/de not_active Expired - Fee Related
- 2004-03-10 PL PL04719030T patent/PL1608407T3/pl unknown
- 2004-03-10 JP JP2006506364A patent/JP2006520779A/ja active Pending
- 2004-03-10 RU RU2005129266/13A patent/RU2325189C2/ru not_active IP Right Cessation
- 2004-03-10 BR BRPI0408556-6A patent/BRPI0408556A/pt not_active IP Right Cessation
- 2004-03-10 EP EP04719030A patent/EP1608407B1/en not_active Expired - Lifetime
- 2004-03-17 US US10/803,146 patent/US20040235803A1/en not_active Abandoned
- 2004-03-18 UY UY28235A patent/UY28235A1/es not_active Application Discontinuation
- 2004-03-18 AR ARP040100903A patent/AR043650A1/es not_active Application Discontinuation
- 2004-03-19 TW TW093107507A patent/TWI262084B/zh not_active IP Right Cessation
- 2004-03-19 CL CL200400573A patent/CL2004000573A1/es unknown
-
2005
- 2005-08-29 ZA ZA200506920A patent/ZA200506920B/en unknown
- 2005-09-15 NO NO20054260A patent/NO20054260L/no not_active Application Discontinuation
- 2005-09-16 CO CO05094075A patent/CO5611169A2/es not_active Application Discontinuation
-
2006
- 2006-10-10 CY CY20061101445T patent/CY1105652T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2270361T3 (es) | 2007-04-01 |
SI1608407T1 (sl) | 2006-12-31 |
BRPI0408556A (pt) | 2006-03-21 |
AU2004222523A1 (en) | 2004-09-30 |
ZA200506920B (en) | 2007-09-26 |
RU2325189C2 (ru) | 2008-05-27 |
CN1761487A (zh) | 2006-04-19 |
KR100717433B1 (ko) | 2007-05-14 |
WO2004082588A2 (en) | 2004-09-30 |
ATE337793T1 (de) | 2006-09-15 |
US20040235803A1 (en) | 2004-11-25 |
JP2006520779A (ja) | 2006-09-14 |
KR20050114249A (ko) | 2005-12-05 |
UY28235A1 (es) | 2004-11-08 |
TWI262084B (en) | 2006-09-21 |
EP1608407B1 (en) | 2006-08-30 |
CO5611169A2 (es) | 2006-02-28 |
MXPA05009978A (es) | 2005-11-04 |
RU2005129266A (ru) | 2006-03-20 |
TW200503756A (en) | 2005-02-01 |
CL2004000573A1 (es) | 2005-01-14 |
NO20054260L (no) | 2005-12-12 |
DK1608407T3 (da) | 2006-12-04 |
WO2004082588A3 (en) | 2004-12-23 |
CA2519125A1 (en) | 2004-09-30 |
PL1608407T3 (pl) | 2006-12-29 |
CY1105652T1 (el) | 2010-12-22 |
DE602004002201D1 (de) | 2006-10-12 |
PT1608407E (pt) | 2006-12-29 |
DE602004002201T2 (de) | 2007-09-20 |
NO20054260D0 (no) | 2005-09-15 |
EP1608407A2 (en) | 2005-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR043650A1 (es) | Formulacion dispersable de un agente antiinflamatorio para ser aplicada en inflamaciones mamarias en animales productores de leche y en inflamaciones oticas | |
UY28236A1 (es) | Composicion farmaceutica dispersable para el tratamiento de mastitis y trastornos oticos. | |
AR042537A1 (es) | Composiciones farmaceuticas dispersables que contienen antibacterianos para animales productores de leche | |
CO5650245A2 (es) | Formulaciones dispersable de un agente anti-inflamatorio | |
US5888523A (en) | Topical non-steroidal anti-inflammatory drug composition | |
CN106176430A (zh) | 一种免洗泡沫型女性杀菌液及其制备方法 | |
JP2019501108A (ja) | 粘膜炎症を抑制するためのイガイ接着タンパク質生成物及びその使用 | |
AU2021200611A1 (en) | Compositions and methods of use | |
ES2963980T3 (es) | Emulsiones para el tratamiento tópico de infecciones dérmicas y mucosas | |
WO2007078402A2 (en) | A layered dosage form for a medicated tampon assembly | |
MD2516B1 (en) | Anti-inflammatory, antiseptic and antimycotic medicament in the form of gel | |
WO2015092719A1 (es) | Composiciones acuosas de complejos de cobre, complejos de cobre poliméricos y aloe vera | |
US20150306062A1 (en) | Treatment and prevention of epithelial infections | |
ES2363539T3 (es) | Composición farmacéutica para el tratamiento de la xerostomía. | |
Sharma et al. | STUDY ON ISOCONAZOLE PRONIOSOMAL GEL IN TREATING FUNGAL INFECTION | |
US20190321289A1 (en) | Drug delivery system | |
TH10572C3 (th) | เจลปิดเนื้อเยื่อในฟัน | |
CN101199499A (zh) | 速效缓释避孕药膜 | |
TH10572A3 (th) | เจลปิดเนื้อเยื่อในฟัน | |
Sattayaprasert et al. | Prostatitis condition in Thai mixed breed dog due to excess sexual using for semen collection. | |
GB2576641A (en) | Plant extract compositions | |
RU94021279A (ru) | Препарат для лечения и профилактики мастита крупного рогатого скота | |
GEP20084374B (en) | Donara chachua ointment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |